Case Report: a novel CYP27A1 gene variant in a patient with cerebrotendinous xanthomatosis with unusual clinical findings

References

• Carson BE, De Jesus O. Cerebrotendinous xanthomatosis. Treasure Island (FL): StatPearls; 2023.
   Google Scholar
• De Carvalho M, Dhamija R, Nadjar Y, et al. Cerebrotendinous xanthomatosis: a practice review of pathophysiology, diagnosis, and treatment. Front Neurol. 2022;13:1049850.
   Google Scholar
• Balkhadir H, Tahiri L, Fathi I, et al. Cerebrotendinous xanthomatosis: a moroccan case report and review of literature. Ann Indian Acad Neurol. 2021;24(5):841. doi: 10.4103/aian.AIAN_1189_20.
   PubMed Web of Science ®Google Scholar
• Koyama S, Sekijima Y, Ogura M, et al. Cerebrotendinous xanthomatosis: molecular pathogenesis, clinical spectrum, diagnosis, and disease-modifying treatments. J Atheroscler Thromb. 2021;28(9):905–925. doi: 10.5551/jat.RV17055.
   PubMed Web of Science ®Google Scholar
• Jiao H, Olin M, Hansson M, et al. Unique case of cerebrotendinous xanthomatosis revisited: all the mutations responsible for this disease are present in the CYP27A1 gene. J Intern Med. 2018;283(6):604–606. doi: 10.1111/joim.12709.
   PubMed Web of Science ®Google Scholar
• Patni N, Wilson DP. Cerebrotendinous xanthomatosis. Feingold KR, Anawalt B, & Blackman MR, Eds. Endotext. 2023.
   Google Scholar
• Pramparo T, Steiner RD, Rodems S, et al. Allelic prevalence and geographic distribution of cerebrotendinous xanthomatosis. Orphanet J Rare Dis. 2023;18(1):13. doi: 10.1186/s13023-022-02578-1.
   PubMed Web of Science ®Google Scholar
• DeBarber AE, Luo J, Star-Weinstock M, et al. A blood test for cerebrotendinous xanthomatosis with potential for disease detection in newborns. J Lipid Res. 2014;55(1):146–154. doi: 10.1194/jlr.P043273.
   PubMed Web of Science ®Google Scholar
• Nie S, Chen G, Cao X, et al. Cerebrotendinous xanthomatosis: a comprehensive review of pathogenesis, clinical manifestations, diagnosis, and management. Orphanet J Rare Dis. 2014;9(1):179. doi: 10.1186/s13023-014-0179-4.
   PubMedGoogle Scholar
• Ribeiro RM, Vasconcelos SC, Lima PLGdSB, et al. Pathophysiology and treatment of lipid abnormalities in cerebrotendinous xanthomatosis: an integrative review. Brain Sci. 2023;13(7):979. doi: 10.3390/brainsci13070979.
   PubMed Web of Science ®Google Scholar
• Sasamura A, Akazawa S, Haraguchi A, et al. Late-onset cerebrotendinous xanthomatosis with a novel mutation in the CYP27A1 gene. Intern Med. 2018;57(11):1611–1616. doi: 10.2169/internalmedicine.0120-17.
   PubMed Web of Science ®Google Scholar
• Fraidakis MJ. Psychiatric manifestations in cerebrotendinous xanthomatosis. Transl Psychiatry. 2013;3(9):e302–e302. doi: 10.1038/tp.2013.76.
   PubMedGoogle Scholar
• Brass EP, Stelten BML, Verrips A. Cerebrotendinous xanthomatosis-associated diarrhea and response to chenodeoxycholic acid treatment. JIMD Rep. 2020;56(1):105–111. doi: 10.1002/jmd2.12163.
   PubMedGoogle Scholar
• Vadapalli S. Cerebrotendinous xanthomatosis. Indian J Orthop. 2013;47(2):200–203. doi: 10.4103/0019-5413.108918.
   PubMed Web of Science ®Google Scholar
• Ma C, Ren YD, Wang JC, et al. The clinical and imaging features of cerebrotendinous xanthomatosis: a case report and review of the literature. Medicine (Baltimore). 2021;100(9):E24687. doi: 10.1097/MD.0000000000024687.
   PubMed Web of Science ®Google Scholar
• Öncel Acır N, Taskiran Kandeger B. Early diagnosis for cerebrotendinous xanthomatosis with juvenile cataract and family history. Ophthalmic Genet. 2023;44(4):361–365. doi: 10.1080/13816810.2023.2197492.
   PubMed Web of Science ®Google Scholar
• Mignarri A, Gallus GN, Dotti MT, et al. A suspicion index for early diagnosis and treatment of cerebrotendinous xanthomatosis. J Inherit Metab Dis. 2014;37(3):421–429. doi: 10.1007/s10545-013-9674-3.
   PubMed Web of Science ®Google Scholar
• Verrips A, Dotti MT, Mignarri A, et al. The safety and effectiveness of chenodeoxycholic acid treatment in patients with cerebrotendinous xanthomatosis: two retrospective cohort studies. Neurol Sci. 2020;41(4):943–949. doi: 10.1007/s10072-019-04169-8.
   PubMed Web of Science ®Google Scholar
• Yahalom G, Tsabari R, Molshatzki N, et al. Neurological outcome in cerebrotendinous xanthomatosis treated with chenodeoxycholic acid: early versus late diagnosis. Clin Neuropharmacol. 2013;36(3):78–83. doi: 10.1097/WNF.0b013e318288076a.
   PubMed Web of Science ®Google Scholar
• Stelten BML, Raal FJ, Marais AD, et al. Cerebrotendinous xanthomatosis without neurological involvement. J Intern Med. 2021;290(5):1039–1047. doi: 10.1111/joim.13277.
   PubMed Web of Science ®Google Scholar
• Guenzel AJ, DeBarber A, Raymond K, et al. Familial variability of cerebrotendinous xanthomatosis lacking typical biochemical findings. JIMD Rep. 2021;59(1):3–9. doi: 10.1002/jmd2.12197.
   PubMedGoogle Scholar
• Chang YY, Yu CQ, Zhu L. Progressive ataxia of cerebrotendinous xanthomatosis with a rare c.255 + 1G > T splice site mutation: a case report. World J Clin Cases. 2022;10(29):10681–10688. doi: 10.12998/wjcc.v10.i29.10681.
   PubMed Web of Science ®Google Scholar
• Lee CW, Lee JJ, Lee YF, et al. Clinical and molecular genetic features of cerebrotendinous xanthomatosis in Taiwan: report of a novel CYP27A1 mutation and literature review. J Clin Lipidol. 2019;13(6):954–959.e1. doi: 10.1016/j.jacl.2019.10.001.
   PubMed Web of Science ®Google Scholar
• Miller B, William Bonham L, Reale C, et al. Case report: cerebrotendinous xanthomatosis with a novel mutation in the CYP27A1 gene mimicking behavioral variant frontotemporal dementia. Front Neurol. 2023;14:1131888.
   Google Scholar
• Sengupta A, Laskar S. A rare case of cerebrotendinous xanthomatosis with typical clinical & radiological features. Indian J Med Res. 2022;156(4&5):699. doi: 10.4103/ijmr.IJMR_424_20.
   PubMed Web of Science ®Google Scholar
• Takasone K, Morizumi T, Nakamura K, et al. A late-onset and relatively rapidly progressive case of pure spinal form cerebrotendinous xanthomatosis with a novel mutation in the CYP27A1 gene. Intern Med. 2020;59(20):2587–2591. doi: 10.2169/internalmedicine.5037-20.
   PubMed Web of Science ®Google Scholar
• Tang Y, Liu Y, Li D, et al. A novel mutation in the CYP27A1 gene in a family with cerebrotendinous xanthomatosis. Int J Neurosci. 2020;130(10):972–975. doi: 10.1080/00207454.2020.1713774.
   PubMed Web of Science ®Google Scholar
• Mahadevan N, Thiruvadi V, P C, et al. Cerebrotendinous xanthomatosis: report of two siblings with the same mutation but variable presentation. Cureus. 2023;15(1):e33378. doi: 10.7759/cureus.33378.
   PubMed Web of Science ®Google Scholar
• Rani D, Singla D, Garg D. Cerebrotendinous xanthomatosis: a rare etiology of the “Hot-Cross bun” sign. Ann Indian Acad Neurol. 2023;26(4):556–557. doi: 10.4103/aian.aian_544_23.
   PubMed Web of Science ®Google Scholar
• Contreras JP, Guajardo G, Martínez A, et al. Xantomatosis cerebrotendinosa sin xantomas tendíneos. Caso clínico cerebrotendinous xanthomatosis. Report of one case. CASOS CLÍNICOS Rev Med Chile. 2019;147(5):658–662.
   PubMed Web of Science ®Google Scholar
• Islam M, Hoggard N, Hadjivassiliou M. Cerebrotendinous xanthomatosis: diversity of presentation and refining treatment with chenodeoxycholic acid. Cerebellum Ataxias. 2021;8(1):5. doi: 10.1186/s40673-021-00128-2.
   PubMedGoogle Scholar
• Kısa PT, Yildirim GK, Hismi BO, et al. Patients with cerebrotendinous xanthomatosis diagnosed with diverse multisystem involvement. Metab Brain Dis. 2021;36(6):1201–1211. doi: 10.1007/s11011-021-00714-7.
   PubMed Web of Science ®Google Scholar
• Degrassi I, Amoruso C, Giordano G, et al. Case report: early treatment with chenodeoxycholic acid in cerebrotendinous xanthomatosis presenting as neonatal cholestasis. Front Pediatr. 2020;8:382. doi: 10.3389/fped.2020.00382.
   PubMed Web of Science ®Google Scholar
• Shaji B, Srikumar B, Ramachandran D. A preventable ataxia: cerebrotendinous xanthomatosis. Ann Indian Acad Neurol. 2019;22(4):493–496. doi: 10.4103/aian.AIAN_126_18.
   PubMed Web of Science ®Google Scholar
• Stelten BML, Huidekoper HH, Van De Warrenburg BPC, et al. Long-term treatment effect in cerebrotendinous xanthomatosis depends on age at treatment start. Neurology. 2019;92(2):E83–E95. doi: 10.1212/WNL.0000000000006731.
   PubMed Web of Science ®Google Scholar
• Hollak CEM. Expanding the clinical spectrum of cerebrotendinous xanthomatosis: implications for newborn screening, follow-up and treatment. J Intern Med. 2021;290(5):942–943. doi: 10.1111/joim.13276.
   PubMed Web of Science ®Google Scholar